Tenet Healthcare (NYSE:THC) Raised to “Strong-Buy” at Wall Street Zen

Tenet Healthcare (NYSE:THC) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other equities research analysts also recently commented on the company. Leerink Partners reaffirmed an “outperform” rating and set a $309.00 target price on shares of Tenet Healthcare in a report on Friday, September 18th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Friday, October 2nd. Guggenheim increased their price target on shares of Tenet Healthcare from $283.00 to $307.00 and gave the stock a “buy” rating in a report on Friday. Stephens reissued an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Eighteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $278.45.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $267.27 on Friday. The business has a fifty day moving average of $264.36 and a 200 day moving average of $219.29. Tenet Healthcare has a 1 year low of $157.58 and a 1 year high of $283.05. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a market capitalization of $21.52 billion, a price-to-earnings ratio of 10.31, a price-to-earnings-growth ratio of 1.02 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare will post 21.04 earnings per share for the current year.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 1,152 shares of Tenet Healthcare stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total transaction of $298,137.60. Following the completion of the transaction, the director owned 23,653 shares in the company, valued at approximately $6,121,396.40. This trade represents a 4.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard Mark sold 10,000 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the transaction, the director directly owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. This trade represents a 28.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 131,199 shares of company stock worth $35,065,587 in the last three months. Company insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of THC. V Square Quantitative Management LLC acquired a new stake in shares of Tenet Healthcare during the 3rd quarter worth approximately $26,000. Mather Group LLC. lifted its stake in shares of Tenet Healthcare by 126.9% in the 3rd quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after purchasing an additional 66 shares during the period. Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $37,000. Fortitude Family Office LLC boosted its holdings in Tenet Healthcare by 52.1% during the third quarter. Fortitude Family Office LLC now owns 222 shares of the company’s stock worth $57,000 after buying an additional 76 shares in the last quarter. Finally, OP Asset Management Ltd purchased a new stake in Tenet Healthcare during the first quarter worth $49,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.